Last reviewed · How we verify
NCT04828655
Analysis of Bioparametric Measures for Correlating Daily Habits and Reducing Blood Pressure
NA trial testing Use of a mobile application based on machine learning with the aim of improving health and body composition parameters. in Hypertension in 36 participants. Completed in 31 May 2021.
7 January 2021
Quick facts
| Lead sponsor | University of Alicante |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 36 |
| Start date | 1 September 2020 |
| Primary completion | 7 January 2021 |
| Estimated completion | 31 May 2021 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Use of a mobile application based on machine learning with the aim of improving health and body composition parameters.
Conditions studied
- Hypertension — all drugs for Hypertension →
- Diet, Mediterranean — all drugs for Diet, Mediterranean →
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
- Exercise — all drugs for Exercise →
Sponsor
University of Alicante
Who can join
40 and older, any sex, with Hypertension or Diet, Mediterranean. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To study the effects of the use of a mobile application plus recommendations based on a Mediterranean diet on the intake of micronutrients from natural sources (not drugs) on health indicators, cardiovascular parameters (blood pressure...), physical condition and body composition in a Spanish adult population.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Digital health technologies and artificial intelligence in cardiovascular clinical trials: A landscape of the European space.
Lampreia F, Madeira C, Dores H. · · 2024 · cited 4× · PMID 39291150 · DOI 10.1177/20552076241277703 -
New App-Based Dietary and Lifestyle Intervention on Weight Loss and Cardiovascular Health.
Martínez-Rodríguez A, Martínez-Olcina M, Mora J, Navarro P, et al · · 2022 · cited 4× · PMID 35161515 · DOI 10.3390/s22030768
Verify or expand the search:
- PubMed search for NCT04828655
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other University of Alicante trials
Trials by the same sponsor.
- NCT07385794 — Design and Validation of a Personalized Preventive System for Adolescents Based on Biological Maturity, Body Composition · NA · not yet recruiting
- NCT06240364 — Effects of AffronEye®/ Crocuvis+® on Dry Eye Syndrome · NA · not yet recruiting
- NCT07104669 — Sports Nutrition Assessment Program · not yet recruiting
- NCT07531953 — Nutritional Knowledge and Characteristics of HYROX Athletes · recruiting
- NCT07269821 — Evaluation of a Nutritional Intervention With Dietary Supplements in People Who Have Recently Lost Weight: Effects on Bo · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04828655 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Alicante
- Last refreshed: 8 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04828655.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing